Strategy to identify subjects with diabetes mellitus more suitable for selective echocardiographic screening: The

Mauro Gori1, Paolo Canova1, Alice Calabrese1

  • 1CardioVascular Department, Ospedale Papa Giovanni XXIII Hospital, Bergamo, Italy.

Insights

A new screening strategy using clinical data and electrocardiograms can identify diabetes patients at high risk for heart failure or death. This approach guides selective echocardiography for better prevention efforts.

Area of Science:

  • Cardiology
  • Endocrinology
  • Preventive Medicine

Background:

  • Pre-clinical heart failure (HF) poses a significant burden on diabetes mellitus (DM) patients.
  • Routine screening echocardiography is not standard for DM patients despite this risk.
  • There is a need for effective strategies to identify high-risk DM individuals for targeted interventions.

Purpose of the Study:

  • To prospectively assess the risk prediction of a screening strategy for HF/death in DM patients.
  • To identify DM patients who would benefit most from selective echocardiography.
  • To evaluate a combined approach using clinical data, ECG, NTproBNP, and echocardiography.

Main Methods:

  • The DAVID-Berg Study enrolled 219 outpatients with DM (aged 55-80) with no prior HF history.
  • Data included clinical variables, electrocardiogram (ECG), NTproBNP, and echocardiography during longitudinal follow-up.
  • A predictive model was developed and refined by adding different components.

Main Results:

  • During a median 5.2-year follow-up, 50 patients developed HF or died.
  • Clinical data plus ECG significantly improved HF/death prediction (C-statistic 0.75) compared to clinical data alone (0.70).
  • Patients with both clinical and ECG abnormalities had a significantly higher event rate (9.0 events/100 person-years), and adding echocardiography further improved prediction (C-statistic 0.80).

Conclusions:

  • A selective echocardiographic screening strategy guided by abnormal clinical and ECG data reliably identifies DM subjects at higher risk for HF and death.
  • This screening approach shows promise for guiding heart failure prevention strategies in diabetes patients.
  • Integrating clinical assessment and ECG can effectively stratify risk in DM patients, optimizing the use of echocardiography.
Abstract